Integrated Nano-Technologies Presents At International Nano Commerce 2003 Meeting And Previews Innovative BioDetect Biological Agent Detector

First Field-Portable Sensor That Rapidly Tests for SARS, Anthrax, Smallpox and More

Rochester, NY (PRWEB) December 8, 2003 ---Integrated Nano-Technologies will address leading companies interested in nanotechnology partnerships by present its innovative new bio-identification technology and preview its product pipeline, at the Nano Commerce 2003 Meeting in Chicago, IL, December 8-11. INT integrates DNA and microelectronics to develop rapid, accurate identification and analysis devices for the biosecurity, clinical diagnostics and a range of other markets.

INTs first product, which will be introduced in early 2004, is the BioDetect biological agent detector/identifier, the first device of its kind that accurately tests for biological agents, such as SARS, anthrax, smallpox, outside the laboratory in less than 20 minutes. BioDetect is a portable, electronic-based DNA detection/identification system that is simple to operate and weighs only 12 pounds. A smaller, even lighter version of the device is already in development and is expected within a year of the initial product launch.

With our patented electronic-based DNA technology, INT has developed some of the most exciting and promising technology in the area of biodetection and identification," said Steve Nazarian, INTs Director of Communications and conference speaker. Our products will offer substantial advances in solving biological detection issues and fill gaps in the fields of biosecurity, medical diagnostics and other markets."

Integrated Nano-Technologies is developing other advanced devices in the areas of biosecurity and public safety, human diagnostics, research and pharmaceutical trials, forensics/DNA fingerprinting, taggants/anti-counterfeiting, veterinary diagnostics, environmental analyses, and food/agriculture safety. An example is the NanoSyringe, a nano-scale, site-specific drug delivery system.

About INTs Technology
Integrated Nano-Technologies core technology platform is a unique integration of molecular biology, chemistry and microeletronics. Biological target identification is based on the ability of DNA probes on a microchip to attract and bind to specific sequences in the DNA of the target organism. DNA is extracted from a sample and passed over the devices microchip, where it attaches to the organism-specific probes. The attached strands are developed through a chemical process, producing an electrical signal for computer analysis.

The BioDetect system, now completing the final testing phase, consists of an electronic analyzer and single-use, disposable test cards. Unlike other detection systems, BioDetect technology does not depend on polymerase chain reaction (PCR), and consequently does not share PCRs shortcomings with respect to speed, stability and sensitivity.

About Integrated Nano-Technologies, LLC
Rochester-based Integrated Nano-Technologies, LLC integrates DNA and microelectronics to develop innovative products for a range of markets. INT is the first company to develop a truly portable, electronic biological agent detection system that rapidly generates accurate results. INT is also developing additional products based on its core technology. For more information about INT, visit the Companys Web site at www.integratednano.com.